LFA
MDT icon

Laraway Financial Advisors’s Medtronic MDT Stock Holding History

Laraway Financial Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Sell
1,841
-453
-20% -$36.5K 0.09% 139
2026
Q1 		$199K Hold
2,294
– – 0.14% 125
2025
Q4 		$220K Sell
2,294
-200
-8% -$19.4K 0.14% 126
2025
Q3 		$238K Buy
+2,494
New +$229K 0.16% 121

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Laraway Financial Advisors's MDT Position: Q2 2026 in Review

Laraway Financial Advisors reduced its Medtronic (MDT) stake by 20% in Q2 2026, selling an estimated $36.5K and leaving 1,841 shares worth $144K. The position accounts for 0.09% of the portfolio, ranked #139.

Laraway Financial Advisors first reported a position in MDT in Q3 2025 and has held it in 4 quarters since. The position peaked at $238K in Q3 2025. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Laraway Financial Advisors held 1,841 shares of Medtronic worth $144K as of Q2 2026.
  • Laraway Financial Advisors sold 453 Medtronic shares in Q2 2026, an estimated $36.5K.
  • Medtronic made up 0.09% of Laraway Financial Advisors's portfolio in Q2 2026, its #139 holding.
  • Laraway Financial Advisors first reported a position in Medtronic in Q3 2025 and has held it in 4 quarters since.
  • Laraway Financial Advisors's Medtronic position peaked at $238K in Q3 2025.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Laraway Financial Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.